Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh

Go back to Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh
(NASDAQ: VRDN) Delayed: 16.35 +0.21 (1.30%)
Previous Close $16.14    52 Week High
Open $16.20    52 Week Low
Day High $16.68    P/E N/A 
Day Low $16.18    EPS
Volume 1,245,296